Epidemiologic profile and clinical outcomes of adult patients with prolactinoma at the Philippine General Hospital
https://doi.org/10.47895/amp.vi0.10588
- Author:
Ma. Belen B. Pilit
1
;
Ma. Cecille Añonuevo-Cruz
1
;
Cecilia A. Jimeno
1
,
2
Author Information
1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Philippine General Hospital, University of the Philippines Manila
2. Department of Pharmacology and Toxicology, College of Medicine, University of the Philippines Manila
- Publication Type:Journal Article
- MeSH:
Prolactinoma;
Pituitary Neoplasms;
Prolactin
- From:
Acta Medica Philippina
2024;58(Early Access 2024):1-8
- CountryPhilippines
- Language:English
-
Abstract:
Background and Objective:Prolactinoma is the most common functioning tumor of the pituitary gland. While its clinical course and outcomes among different populations have been vastly described in the past, data of prolactinoma among Filipinos has not been explored. This paper aims to describe the clinical profile and outcome of prolactinoma among adult Filipino patients.
Methods:We conducted a retrospective cohort study including 41 patients with prolactinoma seen at the Philippine General Hospital. The clinical profile, cranial imaging features, treatment modalities given, and their outcomes over a mean follow up of 16 months were evaluated.
Results:The mean age at diagnosis was 36.76 ±13.99 years. Majority of our cohort were females. Macroprolactinoma were found in 75.61% and giant prolactinoma in 9.76%. The remaining 12.2% were mixed GH and PRL secreting tumors. Most common symptoms at presentation were blurring of vision, headache, and amenorrhea. Median PRL levels was 353 (200-470) ng/ml. Medical therapy with Bromocriptine was the primary treatment modality used in 78% of patients. We found no significant difference between patients who underwent surgical and medical primary treatment modalities in terms of outcomes. At the end of follow up, 82.6 % of patients achieved at least more than 50% reduction in their prolactin levels.
Conclusion:Overall, our study showed that adult Filipino patients with prolactinoma have a larger tumor size at diagnosis and a lower rate of improvement of gonadal function after treatment. There were no statistically significant differences in clinical and biochemical outcomes between the treatment modalities used.
- Full text:20240922235305601921.pdf
